DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on November 15, 2007; DOI: 10.1124/dmd.107.019323


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.107.019323v1
36/2/234    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Osorio-Lozada, A.
Right arrow Articles by Subramanian, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Osorio-Lozada, A.
Right arrow Articles by Subramanian, R.


Received for publication October 18, 2007.
Revised November 9, 2007.
Accepted for publication November 12, 2007.

Biosynthesis of Drug Metabolites Using Microbes in Hollow Fiber Cartridge Reactors: Case Study of Diclofenac Metabolism by Actinoplanes sp

Antonio Osorio-Lozada 1, Sekhar Surapaneni 2, Gary Skiles 1, Raju Subramanian 1*

1 Amgen 2 Celgene

* Address correspondence to: E-mail: rajus{at}amgen.com

Abstract

Fungal and bacterial microbes are known to mimic mammalian cytochrome P450 metabolism. Traditionally, microbial biotransformation screening and small scale-ups (< 1L) are performed in shake-flask reactors. An alternative approach is the use of hollow fiber cartridge (HFC) reactors. The performance of HFC reactors is compared to shake-flask reactors using diclofenac as a model substrate. Actinoplanes sp. (ATCC-53771) in a shake-flask reactor hydroxylated diclofenac (50 µM) with 100% turnover in less than 5 hours. A scaled-up production resulted in the formation of 4'-hydroxy (169 mg, 54% yield), 5-hydroxy (42 mg, 13 % yield) and 4’,5-dihydroxy (25 mg, 7.7% yield) metabolites. HFC reactors with Teflon, poly-sulfone, and cellulose membranes were screened for non-specific binding of diclofenac. Concentration-time profiles for turnover of 50-2000 µM diclofenac by Actinoplanes sp. were then determined at 22ºC and 30 °C in an HFC reactor. Cellulose-based HFC reactors exhibited the lowest non-specific binding (87% of 50 µM diclofenac remaining after 5 hr) and offered the best conditions for its biotransformation (100% conversion; < 5hr at 30 °C at 50 µM; 25 hr at 500 µM). The time profile for substrate turnover was equivalent in both a cellulose membrane HFC reactor and shake-flask reactor. Two cellulose membrane HFC reactors were also tested to evaluate the reusability of the cartridges for diclofenac metabolism (50 µM, 22 °C, 15 hr; 500 µM, 30 °C, 36 hr). Up to seven reaction cycles with intermediate wash cycles were tested. At least 98 % conversion was observed in each reaction cycle at both diclofenac concentrations.


Key words: anti-inflammatory drugs, cytochrome P450 catalyzed oxidations, HPLC, mass spectrometry, metabolite identification, structure elucidation





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.